These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28779830)

  • 1. Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit.
    Gilbert DN
    Infect Dis Clin North Am; 2017 Sep; 31(3):435-453. PubMed ID: 28779830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
    Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
    Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia.
    Gilbert D; Gelfer G; Wang L; Myers J; Bajema K; Johnston M; Leggett J
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):102-7. PubMed ID: 27377675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.
    Self WH; Balk RA; Grijalva CG; Williams DJ; Zhu Y; Anderson EJ; Waterer GW; Courtney DM; Bramley AM; Trabue C; Fakhran S; Blaschke AJ; Jain S; Edwards KM; Wunderink RG
    Clin Infect Dis; 2017 Jul; 65(2):183-190. PubMed ID: 28407054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
    Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
    Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
    J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP.
    Nyamande K; Lalloo UG
    Int J Tuberc Lung Dis; 2006 May; 10(5):510-5. PubMed ID: 16704032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.
    Jereb M; Kotar T
    Wien Klin Wochenschr; 2006 Apr; 118(5-6):170-4. PubMed ID: 16773483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
    Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
    Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
    Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
    Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
    Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
    Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis.
    Hedlund J; Hansson LO
    Infection; 2000; 28(2):68-73. PubMed ID: 10782390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria.
    Yan ST; Sun LC; Jia HB; Gao W; Yang JP; Zhang GQ
    Am J Emerg Med; 2017 Apr; 35(4):579-583. PubMed ID: 27979420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.
    Niederman MS
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S127-32. PubMed ID: 18986278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity.
    Johansson N; Kalin M; Backman-Johansson C; Larsson A; Nilsson K; Hedlund J
    Scand J Infect Dis; 2014 Nov; 46(11):787-91. PubMed ID: 25195651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.
    Cunha BA
    Scand J Infect Dis; 2009; 41(10):782-4. PubMed ID: 19681019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.